Solid-phase synthesis, bioconjugation, and toxicology of novel cationic oligopeptoids for cellular drug delivery

Bioconjugate Chemistry

Volumn 18, Issue 2, 2007, Pages 342-354

  Schröder, Tina ^a   Schmitz, Katja ^b   Niemeier, Nicole ^a,c   Balaban, Teodor S ^a,c   Krug, Harald F ^a,c   Schepers, Ute ^b   Bräse, Stefan ^a  

^a UNIVERSITY OF KARLSRUHE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELLS; CONTROLLED DRUG DELIVERY; CYTOLOGY; EFFICIENCY; PEPTIDES; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

BIO-CONJUGATION; CARGO MOLECULES; CATIONICS; CELL-PENETRATING PEPTIDE; CELLULARS; DRUG MOLECULES; PEPTOIDS; SOLID PHASE SYNTHESIS; SYNTHETIC COMPOUNDS; THERAPEUTIC APPLICATION;

PORPHYRINS;

BETA PEPTIDE; DYE; GLYCINE DERIVATIVE; LACTATE DEHYDROGENASE; PEPTOID; PORPHYRIN DERIVATIVE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CELLULAR DISTRIBUTION; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHIRALITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DRUG DELIVERY SYSTEM; ENZYME ASSAY; FIBROBLAST CULTURE; FLUORESCENCE MICROSCOPY; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MAMMAL CELL; NEUROBLASTOMA CELL; NONHUMAN; PEPTIDE SYNTHESIS; PHOTOTOXICITY; SOLID; TUMOR CELL CULTURE;

EID: 33947668354     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0602073     Document Type: Article

References (40)

1. Frankel, A. D., and Pabo, C. O. (1988) Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-93.
2. Green, M., and Loewenstein, P. M. (1988) Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55, 1179-88.
3. Wender, P. A., Mitchell, D. J., Pattabiraman, K., Pelkey, E. T., Steinman, L., and Rothbard, J. B. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97, 13003-8.
4. Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., and Barsoum, J. (1994) Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U.S.A. 91, 664-8.
5. Pepinsky, R. B., Androphy, E. J., Corina, K., Brown, R., and Barsoum, J. (1994) Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its represser. DNA Cell Biol. 13, 1011-9.
6. Vives, E., Charneau, P., van Rietschoten, J., Rochat, H., and Bahraoui, E. (1994) Effects of the Tat basic domain on human immunodeficiency virus type 1 transactivation, using chemically synthesized Tat protein and Tat peptides. J. Virol. 68, 3343-53.
7. Vives, E., Brodin, P., and Lebleu, B. (1997) A truncated HIV-I Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-7.
8. Derossi, D., Joliot, A. H., Chassaing, G., and Prochiantz, A. (1994) The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-50.
9. Elliott, G., and Ohare, P. (1997) Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell 88, 223-233.
10. Lindgren, M., Hallbrink, M., Prochiantz, A., and Langel, U. (2000) Cell-penetrating peptides. Trends Pharmacol. Sci. 21, 99-103.
11. Jeang, K. T., Xiao, H., and Rich, E. A. (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem. 274, 28837-40.
12. Nagahara, H., Vocero-Akbani, A. M., Snyder, E. L., Ho, A., Latham, D. G., Lissy, N. A., Becker-Hapak, M., Ezhevsky, S. A., and Dowdy, S. F. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kipl induces cell migration. Nat. Med. 4, 1449-52.
13. Schwarze, S. R., and Dowdy, S. F. (2000) In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. 21, 45-48.
14. Schwarze, S. R., Hruska, K. A., and Dowdy, S. F. (2000) Protein transduction: unrestricted delivery into all cells? Trends Cell Biol. 10, 290-295 (review).
15. Emi, N., Kidoaki, S., Yoshikawa, K., and Saito, H. (1997) Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate. Biochem. Biophys. Res. Commun. 231, 421-4.
16. Hallbrink, M., Floren, A., Elmquist, A., Pooga, M., Bartfai, T., and Langel, U. (2001) Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515, 101-9.
17. Mi, Z., Mai, J., Lu, X., and Robbins, P. D. (2000) Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol. Ther. 2, 339-47.
18. Ho, A., Schwarze, S. R., Mermelstein, S. J., Waksman, G., and Dowdy, S. F. (2001) Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61, 474-7.
19. Rothbard, J. B., Garlington, S., Lin, Q., Kirschberg, T., Kreider, E., McGrane, P. L., Wender, P. A., and Khavari, P. A. (2000) Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6, 1253-7.
20. Wender, P. A., Rothbard, J. B., Jessop, T. C., Kreider, E. L., and Wylie, B. L. (2002) Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J. Am. Chem. Soc. 124, 13382-3.
21. Raguse, T. L., Porter, E. A., Weisblum, B., and Gellman, S. H. (2002) Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc. 124, 12774-85.
22. Rueping, M., Mahajan, Y., Sauer, M., and Seebach, D. (2002) Cellular uptake studies with beta-peptides. Chem. Biochem. 3, 257-9.
23. Potocky, T. B., Menon, A. K., and Gellman, S. H. (2003) Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells. J. Biol. Chem. 278, 50188-94.
24. Rueping, M., Mahajan, Y. R., Jaun, B., and Seebach, D. (2004) Design, synthesis and structural investigations of a beta-peptide forming a 314-helix stabilized by electrostatic interactions. Chemistry 10,1607-15.
25. Wadia, J. S., and Dowdy, S. F. (2003) Modulation of cellular function by TAT mediated transduction of full length proteins. Curr. Protein Pept. Sci 4, 97-104.
26. Goff, D. A., and Zuckermann, R. N. (1992) Solid phase synthesis of highly substituted peptoid 1(2H) isoquinolinones. Proc. Natl. Acad. Sci U.S.A. 60, 5748-9.
27. Figliozzi, G. M., Goldsmith, R., Ng, S. C., Banville, S. C., and Zuckermann, R. N. (1996) Synthesis of N-substituted glycine peptoid libraries. Methods Enzymol. 267, 437-47.
28. Uno, T., Beausoleil, E., Goldsmith, R. A., Levine, B. H., and Zuckermann, R. N. (1999) New submonomers for poly N-substituted glycines (peptoids). Tetrahedron Lett. 40, 1475-1478.
29. Wu, C. W., Sanborn, T. J., Zuckermann, R. N., and Barron, A. E. (2001) Peptoid oligomers with alpha-chiral, aromatic side chains: effects of chain length on secondary structure. J. Am. Chem. Soc. 123, 2958-63.
30. Wu, C. W., Kirshenbaum, K., Sanborn, T. J., Patch, J. A., Huang, K., Dill, K. A., Zuckermann, R. N., and Barron, A. E. (2003) Structural and spectroscopic studies of peptoid oligomers with alpha-chiral aliphatic side chains. J. Am. Chem. Soc. 125, 13525-30.
31. Peretto, I., Sanchez-Martin, R. M., Wang, X. H. Ellard, J., Mittoo, S., and Bradley, M. (2003) Cell penetrable peptoid carrier vehicles: synthesis and evaluation. Chem. Commun. 2312-3.
32. Kirshenbaum, K., Barron, A. E., Goldsmith, R. A., Armand, P., Bradley, E. K., Truong, K. T., Dill, K. A., Cohen, F. E., and Zuckermann, R. N. (1998) Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc. Natl. Acad. Sci. U.S.A. 95, 4303-8.
33. Lundberg, P., Magzoub, M., Lindberg, M., Hallbrink, M., Jarvet, J., Eriksson, L. E., Langel, U., and Graslund, A. (2002) Cell membrane translocation of the N-terminal (1-28) part of the prion protein. Biochem. Biophys. Res. Commun. 299, 85-90.
34. Richard, J. P., Melikov, K., Vives, E., Ramos, C., Verbeure, B., Gait, M. J., Chernomordik, L. V., and Lebleu, B. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278, 585-90.
35. Kichler, A., Leborgne, C., Danos, O., and Bechinger, B. (2007) Characterization of the gene transfer process mediated by histidine-rich peptides. J. Mol. Med 85, 191-201.
36. Mason, A. J., Gasnier, C., Kichler, A., Prevost, G., Aunis, D., Metz-Boutigue, M. H., and Bechinger, B. (2006) Enhanced-membrane disruption and antibiotic action against pathogenic bacteria by designed histidine-rich peptides at acidic pH. Antimicrob. Agents Chemother. 50,3305-11.
37. Balaban, T. S., Eichhofer, A., and Lehn, J. M. (2000) Self-assembly by hydrogen bonding and pi-pi interactions in the crystal of a porphyrin - Attempts to mimic bacteriochlorophyll c. Eur. J. Org. Chem. 4047-4057.
38. Berridge, M. V., Herst, P. M., and Tan, A. S. (2005) Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol. Annu. Rev. 11, 127-52.
39. Berridge, M. V., and Tan, A. S. (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate depen-dence, and involvement of mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys. 303, 474-82.
40. Wörle-Knirsch, J. M., Pulskamp, K., and Krug, H. F. (2006) Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 6, 1261-8.